|
Analysis of exhaled breath of lung cancer patients using infrared spectroscopy. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
James Charles Roger Michael |
Honoraria - Bristol-Myers Squibb; Eisai |
Consulting or Advisory Role - Roche; Taiho Pharmaceutical |
|
|
Consulting or Advisory Role - Picomole (Inst) |
Research Funding - Picomole (Inst) |
Patents, Royalties, Other Intellectual Property - Picomole |
|
|
Research Funding - Picomole (Inst) |
Patents, Royalties, Other Intellectual Property - Picomole |
|
|
Consulting or Advisory Role - Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
|
Stock and Other Ownership Interests - GlaxoSmithKline; Pfizer; Picomole |
Patents, Royalties, Other Intellectual Property - Picomole |
Travel, Accommodations, Expenses - Picomole |
Other Relationship - Picomole |
|
|
|
|
Stock and Other Ownership Interests - Picomole |
Patents, Royalties, Other Intellectual Property - Picomole |
|
|
|
Research Funding - Picomole |
|
|
Honoraria - Amgen; Astellas Oncology; AstraZeneca; Bristol-Myers Squibb; Canadian Urological Association (CUA); Celgene; Consumer Vision; Creative; Exactis Innovation; Health Day; IO symposium; Ipsen; Janssen; Johnson & Johnson; Merck; NB Urology; NB Urology; Novartis; Pfizer; Roche; Sanofi; Shire; Taiho Pharmaceutical; Takeda; Vitalite; Yew Tree Consulting |
Consulting or Advisory Role - AstraZeneca; Genomic Health; Ipsen; Janssen; Johnson & Johnson; Merck; Novartis; Odonate Therapeutics; Pfizer; Taiho Pharmaceutical; Takeda |
Speakers' Bureau - AstraZeneca; Canadian Urological Association (CUA); Novartis; Roche |
Research Funding - Abbvie (Inst); Amgen (Inst); Aragon Pharmaceuticals (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Canadian cancer trials group (Inst); Eisai (Inst); Exactis Innovation (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Merck KGaA (Inst); Merck Serono (Inst); Novartis (Inst); Odonate Therapeutics (Inst); OncoSec (Inst); Pfizer (Inst); Pharmacyclics (Inst); Picomole (Inst); Puma Biotechnology (Inst); Purdue Pharma (Inst); Quebec Clinical Research Organization in Cancer (Q-CROC) (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst); Turnstone Bio (Inst); United Therapeutics (Inst) |